Weibin Zhang (Qiyuan Bao)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 6

Top Topics

Chronic Myeloid Leukemia

Tyrosine Kinase

Ejection Fraction

Advanced Non Small Cell Lung Cancer

Top Venues

Journal of clinical medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Zhusheng Zhang, Weibin Zhang, Yucheng Fu, Junxiang Wen, Meng Li, Zhuochao Liu, Guoyu He, Beichen Wang, Yuhui Shen, Weibin Zhang
The Outcome of Discontinuing Tyrosine Kinase Inhibitors in Advanced Sarcoma Following a Favorable Tumor Response to Antiangiogenics Therapy. Journal of clinical medicine 12 (1) (2022)
Zhusheng Zhang, Weibin Zhang, Yucheng Fu, Junxiang Wen, Meng Li, Zhuochao Liu, Guoyu He, Beichen Wang, Yuhui Shen, Weibin Zhang
The Outcome of Discontinuing Tyrosine Kinase Inhibitors in Advanced Sarcoma Following a Favorable Tumor Response to Antiangiogenics Therapy. Journal of clinical medicine 12 (1) (2022)
Zhusheng Zhang, Weibin Zhang, Yucheng Fu, Junxiang Wen, Meng Li, Zhuochao Liu, Guoyu He, Beichen Wang, Yuhui Shen, Weibin Zhang
The Outcome of Discontinuing Tyrosine Kinase Inhibitors in Advanced Sarcoma Following a Favorable Tumor Response to Antiangiogenics Therapy. Journal of clinical medicine 12 (1) (2022)
Yan Zhou, Qing-Cheng Yang, Yang Dong, Tong Ji, Bing Zhang, Cheng Yang, Shuier Zheng, Lina Tang, Chenliang Zhou, Guowei Qian, Yujing Huang, Wenxi Yu, Hongtao Li, Yonggang Wang, Aina He, Zan Shen, Weibin Zhang, Yingqi Hua, Hongyu Bai, Jiayi Zhao, Benjamin X Li, Xiangrong Dai, Jianjun Zhang, Hai-Yan Hu, Yang Yao
First-in-maintenance therapy for localized high-grade osteosarcoma: an open-label phase I/II trial of the anti-PD-L1 antibody ZKAB001. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Zhusheng Zhang, Weibin Zhang, Yucheng Fu, Junxiang Wen, Meng Li, Zhuochao Liu, Guoyu He, Beichen Wang, Yuhui Shen, Weibin Zhang
The Outcome of Discontinuing Tyrosine Kinase Inhibitors in Advanced Sarcoma Following a Favorable Tumor Response to Antiangiogenics Therapy. Journal of clinical medicine 12 (1) (2022)
Zhuochao Liu, Hongyi Wang, Chuanzhen Hu, Chuanlong Wu, Jun Wang, Fangqiong Hu, Yucheng Fu, Junxiang Wen, Weibin Zhang
Targeting autophagy enhances atezolizumab-induced mitochondria-related apoptosis in osteosarcoma. Cell death & disease 12 (2) (2021)